Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS

Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS. Blin, Patrick; Dureau-Pournin, Caroline; Bénichou, Jacques; Cottin, Yves; Mismetti, Patrick; Abouelfath, Abdelilah; Lassalle, Regis; Droz, Cécile; Moore, Nicholas. American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions. 2020; 20: p.81-103. doi:10.1007/s40256-019-00359-z
Article